All stock lists
Atrium Therapeutics, Inc. (NASDAQ:RNA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$6.92-$0.06 (-0.86%)
Market cap
$149M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 27, 2026
Website
Insider Score
––Not scored
RNA Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
RNA Stock Institutional Owners
Scanning latest 13F filings on SEC EDGAR…
Source: SEC EDGAR Form 13F filings (institutions filing within the last ~4 months).
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
